The Journal of Obstetrics and Gynecology of India

, Volume 64, Issue 3, pp 175–179

A Comparative Study of Oxytocin/Misoprostol/Methylergometrine for Active Management of the Third Stage of Labor

  • Megha Sharma
  • Parneet Kaur
  • Khushpreet Kaur
  • Arvinder Kaur
  • Preet Kanwal Kaur
  • Mohi Manjit Kaur
Original Article

DOI: 10.1007/s13224-014-0512-9

Cite this article as:
Sharma, M., Kaur, P., Kaur, K. et al. J Obstet Gynecol India (2014) 64: 175. doi:10.1007/s13224-014-0512-9

Abstract

Objectives

To study oxytocin, misoprostol, and methylergometrine in active management of the third stage of labor and determine duration of the third stage of labor, blood loss, adverse effects, and need for additional uterotonics in each group.

Methods

Clinical trial of 300 women with healthy singleton pregnancy allocated into three groups to receive either: 10 IU intravenous oxytocin infusion, 600 μg sublingual misoprostol, or 200 μg intravenous methylergometrine. Primary outcome measure was blood loss in the third stage of labor; secondary measures were duration of the third stage, side effects, and complications.

Results

Subjects who received 600 μg of misoprostol had the least blood loss, followed by oxytocin, and methylergometrine. The shortest mean duration of the third stage was with misoprostol. Shivering and pyrexia were observed in misoprostol group, and raised blood pressure in methylergometrine group.

Conclusions

Misoprostol is as effective as oxytocin and both are more effective than methylergometrine in active management of the third stage of labor.

Keywords

Third stageActive managementPPH

Copyright information

© Federation of Obstetric & Gynecological Societies of India 2014

Authors and Affiliations

  • Megha Sharma
    • 1
  • Parneet Kaur
    • 1
  • Khushpreet Kaur
    • 1
  • Arvinder Kaur
    • 1
  • Preet Kanwal Kaur
    • 1
  • Mohi Manjit Kaur
    • 1
  1. 1.Department of Obstetrics and GynaecologyGMC and Rajindra HospitalPatialaIndia